Comerica Bank’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.19M Buy
52,056
+22,392
+75% +$903K 0.01% 1077
2025
Q3
$1.02M Buy
29,664
+28,918
+3,876% +$830K ﹤0.01% 1532
2025
Q2
$20.2K Sell
746
-160
-18% -$4.63K ﹤0.01% 3051
2025
Q1
$26.9K Sell
906
-276
-23% -$10.5K ﹤0.01% 2962
2024
Q4
$46.8K Sell
1,182
-76
-6% -$2.88K ﹤0.01% 2827
2024
Q3
$42.8K Sell
1,258
-613
-33% -$17.2K ﹤0.01% 2828
2024
Q2
$40.5K Buy
1,871
+73
+4% +$1.53K ﹤0.01% 2809
2024
Q1
$39.8K Sell
1,798
-150
-8% -$3.66K ﹤0.01% 2820
2023
Q4
$53.6K Buy
1,948
+14
+0.7% +$338 ﹤0.01% 2701
2023
Q3
$43.2K Sell
1,934
-8,902
-82% -$229K ﹤0.01% 2748
2023
Q2
$34 Buy
+10,836
New +$263K ﹤0.01% 230
2022
Q4
$1M Buy
+37,600
New +$874K 0.01% 1438

Other funds holding VCYT

Comerica Bank's VCYT Position: Q4 2025 in Review

Comerica Bank increased its Veracyte (VCYT) stake by 75% in Q4 2025, buying an estimated $903K and bringing the position to 52,056 shares worth $2.19M. The position accounts for 0.01% of the portfolio, ranked #1077.

Comerica Bank first reported a position in VCYT in Q4 2022 and has held it in 12 quarters since. 329 funds tracked by Wall St. Rank hold VCYT as of Q4 2025.

  • Comerica Bank held 52,056 shares of Veracyte worth $2.19M as of Q4 2025.
  • Comerica Bank bought 22,392 Veracyte shares in Q4 2025, an estimated $903K.
  • Veracyte made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #1077 holding.
  • Comerica Bank first reported a position in Veracyte in Q4 2022 and has held it in 12 quarters since.
  • 329 funds tracked by Wall St. Rank held Veracyte as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.